# RNA-Lipid Particle (RNA-LP) Vaccines for Recurrent Adult Glioblastoma (GBM)

> **NCT06389591** · PHASE1 · RECRUITING · sponsor: **University of Florida** · enrollment: 24 (estimated)

## Conditions studied

- Recurrent Glioblastoma

## Interventions

- **BIOLOGICAL:** pp65 RNA loaded lipid particles, pp65 RNA-LPs (Drug Product 1 or DP1)
- **BIOLOGICAL:** RNA loaded lipid particles, RNA-LPs (Drug Product 2 or DP2)

## Key facts

- **NCT ID:** NCT06389591
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-02
- **Primary completion:** 2026-12-01
- **Final completion:** 2027-12-01
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-05-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06389591

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06389591, "RNA-Lipid Particle (RNA-LP) Vaccines for Recurrent Adult Glioblastoma (GBM)". Retrieved via AI Analytics 2026-06-27 from https://api.ai-analytics.org/clinical/NCT06389591. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*